Pharma's Next AI Battleground: Content Velocity & Field Execution

The European pharmaceutical market, worth €313 billion in exports and running a €194 billion trade surplus, is under structural margin pressure that isn't reversing. With patent cliffs threatening $300B+ in lost revenue, rising tariffs, and stricter regulation, brands in the sector are facing growing complexity across content compliance, field execution and commercial performance at scale.

In this context, AI becomes a real competitive lever: not as technology to showcase, but as an operational infrastructure capable of uniting content velocity and field execution into one decisioning system.

Our new paper, The Commercial Bottleneck: Why Content Velocity and Field Execution Are Pharma's Next AI Battleground, analyzes this shift and shows where AI can generate the most concrete impact, from MLR review to rep-HCP engagement.

👉 Inside the paper you'll find:

• The state of the pharma commercial landscape, and why competitive pressure is shifting from pipeline to execution speed
• The structural headwinds reshaping the sector: patent cliffs, tariffs, M&A, and cross-border licensing
• How AI + execution partners cut MLR cycle time by 40–60%, live in weeks rather than quarters
• The regulatory framework tightening around content: FDA enforcement, MLR review and the EU AI Act's Article 50
• The four structural gaps holding pharma back: rep time lost to admin, HCP engagement mismatch, slow content deployment, and fragmented AI adoption
• Five concrete AI use cases: agentic field-force AI, content tagging, MLR pre-check, next-best-action, and content personalization
• Three high-impact pilots to start with, with clear objectives, inputs and measurable KPIs

A read designed for commercial leads, marketing directors, regulatory affairs heads and digital transformation leaders in pharma organizations looking to turn AI experimentation into measurable commercial advantage.

📩 Download the full white paper and discover where AI can generate real value for your commercial operations today.